Airway Medix S.A (AWM) Fair Value & Analysis
Healthcare · PL · Market cap 34.1M PLN
Fair value as of: Jul 19, 2026
From 6 valuation models · updated 22 days ago
Share price +0.6% over the past month.
Below-average quality, and screening another 55% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (0.1615 PLN). The favourable scenario is already priced in.
- Weak quality (14/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range (0.0765 PLN to 0.1615 PLN) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 19, 2026.
How to read this chart
60‑month range 0.2100 PLN – 1.76 PLN · fair‑value band 0.0765 PLN – 0.1615 PLN · the 0.2660 PLN price screens above the 0.1190 PLN fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 19, 2026.
Analysis
Airway Medix S.A (AWM) currently trades at 0.2660 PLN, while our model-based Fair Value estimate is 0.1190 PLN, implying the stock looks roughly 55.3% overvalued today. The Quality Score stands at 14/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Trailing-twelve-month revenue stands at 89.0K PLN. Revenue declined 63.6% year over year. It earns a return on equity of 11.3%. Net debt stands at 12.7M PLN. Fundamentals as of Jul 19, 2026
Our scenario range runs from 0.0765 PLN (bear case) to 0.1615 PLN (bull case); at 0.2660 PLN, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 47% below its 52-week high and 12% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -43% fair-value upside, at -55%, AWM screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 6 models by family
Widest divergence: Growth Earnings (0.6200 PLN) versus DCF Models (0.3000 PLN). Highest evidence: Growth-Adj P/E (68).
Notify me when AWM reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 19, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 17 · Market factors (momentum, volatility) 29
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Airway Medix S.A. engages in the research, development, and commercialization of medical devices for the mechanically ventilated patients in the intensive care units and for the patients in life-threatening conditions in the anaesthesiology departments in Poland and internationally.
Full company description
Airway Medix S.A. engages in the research, development, and commercialization of medical devices for the mechanically ventilated patients in the intensive care units and for the patients in life-threatening conditions in the anaesthesiology departments in Poland and internationally. It offers Closed Suction System, a dual operation of balloon swiping and suction; B-Oral Care for intubated hospital patients; Hyper Form, a ventilation laryngeal masks and tube cuffs; and Cuff Pressure Regulator, single-patient use device that provides continuous regulation of pressure in inflatable ventilation tube cuffs. Airway Medix S.A. was founded in 2010 and is based in Warsaw, Poland.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Airway Medix S.A reported revenue of 4.0K PLN in FY2025 versus 6.0K PLN in FY2021, a compound −9.6%/yr. Reported net income was 1.7M PLN in FY2025.
AWM screens 55% overvalued. Compare with Intuitive Surgical, Inc →
Peer Group
Medical Instruments & Supplies · 203 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $402.33 | $150.04 | -63% |
| EssilorLuxottica Société anonyme 1EL | €172.45 | €68.55 | -60% |
| Medline Inc MDLN | $41.11 | $30.15 | -27% |
| Becton, Dickinson and Company BDX | $150.65 | $103.53 | -31% |
| Alcon Inc ALC | $70.26 | $39.78 | -43% |
| ResMed Inc RMD | $203.87 | $187.89 | -8% |
| West Pharmaceutical Services, Inc WST | $353.71 | $143.97 | -59% |
| Straumann Holding STMN | CHF 106.00 | CHF 47.31 | -55% |
| Sartorius Stedim Biotech S.A DIM | €188.50 | €51.16 | -73% |
| Coloplast A/S COLOB | kr 414.00 | kr 382.22 | -8% |
Compare Airway Medix S.A with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Airway Medix S.A (AWM) overvalued or undervalued?
What is the fair value of AWM?
What is the quality score of AWM?
What is the revenue of Airway Medix S.A (AWM)?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Airway Medix S.A and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.